Devices & Diagnostics

SpineForm raising $1M for scoliosis device

SpineForm has raised more than half of a hoped for $1 million to further development of a scoliosis-treating medical device. The company has raised $539,000 in equity from 14 investors, according to a regulatory filing with the U.S. Securities and Exchange Commission (SEC). The latest SEC document is an amendment to a filing from last […]

SpineForm has raised more than half of a hoped for $1 million to further development of a scoliosis-treating medical device.

The company has raised $539,000 in equity from 14 investors, according to a regulatory filing with the U.S. Securities and Exchange Commission (SEC).

The latest SEC document is an amendment to a filing from last year in which the company said it had raised $464,000 in equity from 12 investors.

CEO Joe Reynolds declined comment.

SpineForm was founded in 2004 to commercialize technology developed at Cincinnati Children’s Hospital Medical Center. The company is developing a “spine staple” to correct without surgery a curvature of the spine known as scoliosis. The company hopes the device slows the effects of scoliosis in children and decreases the curvature as children get older.

In addition to Cincinnati Children’s, SpineForm has received investment funding from state-supported investment group CincyTech and angel group Queen City Angels.

The company has also received a $1 million grant through Ohio’s Third Frontier program.

Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.

Brandon Glenn is the Ohio bureau chief for MedCity News.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.